Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drowsy driving warnings

This article was originally published in The Tan Sheet

Executive Summary

"Warnings about medications that cause drowsiness should be made much stronger," a telephone survey for the Advocates for Highway and Auto Safety concludes. Partially funded by Schering- Plough, the survey report, released May 7, says 52% of those surveyed are "very aware" that "drowsiness in driving might be caused by people who are taking medications which may make them nod off when they are driving,"; 85% "believe it is important that people who take such [drowsiness-causing] medications should be warned specifically not to drive a car after taking them or should take other medications which help then for their condition but do not cause drowsiness." The report adds: "Obviously, if there are medications which help a condition and do not cause drowsiness, people want very much to know about them." Schering markets Claritin (loratadine), an Rx non-sedating antihistamine...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088411

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel